Vanguard Group Inc Adma Biologics, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 14,516,652 shares of ADMA stock, worth $281 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,516,652
Previous 12,689,394
14.4%
Holding current value
$281 Million
Previous $83.8 Million
93.79%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$362 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$255 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$173 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$156 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY6.82MShares$132 Million0.08% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.81B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...